OCM
KRRO icon

Orion Capital Management’s Korro Bio KRRO Stock Holding History

Orion Capital Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20
Closed -$959 – 517
2023
Q4 		$959 Hold
20
– – ﹤0.01% 488
2023
Q3 		$370 Buy
+20
New +$502 ﹤0.01% 496
2023
Q2 		– Sell
-20
Closed -$503 – 307
2023
Q1 		$503 Buy
+20
New +$2.28K ﹤0.01% 448

Other funds holding KRRO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Orion Capital Management's KRRO Position: Q1 2024 in Review

Orion Capital Management sold out of Korro Bio (KRRO) in Q1 2024, closing a stake of 20 shares — an estimated $959 sold.

Orion Capital Management first reported a position in KRRO in Q1 2023 and held it in 3 quarters. The position peaked at $959 in Q4 2023. 49 funds tracked by Wall St. Rank hold KRRO as of Q1 2024.

  • Orion Capital Management reported no remaining Korro Bio position as of Q1 2024 after selling out during the quarter.
  • Orion Capital Management sold 20 Korro Bio shares in Q1 2024, an estimated $959.
  • Orion Capital Management first reported a position in Korro Bio in Q1 2023 and held it in 3 quarters.
  • Orion Capital Management's Korro Bio position peaked at $959 in Q4 2023.
  • 49 funds tracked by Wall St. Rank held Korro Bio as of Q1 2024.

Based on Orion Capital Management's 13F filing for Q1 2024, filed 10 May 2024.